COUR

Coursera, Inc.

NYSE · Services-Prepackaged Software · Inc. DE · CIK 0001651562
$5.33 +0.57% $902.5M
Insider Selling Cluster (2 insiders)18 New Institutional Positions16 Institutional Exits
Vol
Market Cap$902.5M
Cap SizeSmall Cap
Analyst ConsensusBuy (67%)
Inst. Holders50 funds
Inst. Value$470.2M
Inst. Activity18 buys / 16 sells
Insider Activity0B / 4S
Insider Net $-$7.0M
Reddit Sentiment75° Bullish
SEC Reports9
Exchange NYSE·Sector Services-Prepackaged Software·Inc. DE·CIK 0001651562·Prev Close $5.30

Recent Activity

Jun 16, 2026 short_volume
Short Volume: COUR — 63.6% short (1.8M / 2.8M)
Short: 1,778,983 | Exempt: 0 | TRF Vol: 2,796,777 | Short Ratio: 63.6% | Off-exchange volume (dark p
Jun 11, 2026 SEC
{ "summary": "Institutional 13F filings reveal a net distribution pattern in Coursera (COUR): five institutions reduce
INST-CLUSTER — Impact 5/10
Jun 11, 2026 Insider
Maco Marylou was granted 34,260 shares
Director
Jun 11, 2026 Insider
Ng Andrew Y. was granted 34,260 shares
Director
Jun 11, 2026 Insider
MITCHELL THEODORE was granted 34,260 shares
Director
Jun 1, 2026 SEC
Two Coursera insiders sold $1.62M in stock over a 5-trading-day window, driven largely by a 10% owner (Insight Holdings
CLUSTER — Impact 4/10
May 21, 2026 SEC
Two insiders at Coursera sold shares in the open market, led by a 10% owner (Insight Holdings) selling $447K worth of st
CLUSTER — Impact 2/10
Inst.
AMERIPRISE FINANCIAL INC — ADD
4,563,905 shares ($26.6M)

Price Targets

$8.00 +50.1% upside Strong Buy
Current $5.33 Low $5.50 Median $7.75 High $10.00 10 analysts
$5.50 $10.00

Analyst Ratings

Buy67% buy · 18 analysts
3Strong Buy
9Buy
5Hold
1Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Apr 27, 2026 BMO Capital MAINTAIN Outperform → Outperform
Apr 24, 2026 JP Morgan MAINTAIN Overweight → Overweight
Apr 24, 2026 Needham REITERATE Buy → Buy
Feb 9, 2026 Goldman Sachs MAINTAIN Sell → Sell
Feb 6, 2026 RBC Capital MAINTAIN Outperform → Outperform

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.09 $0.07 — $0.10 -29% YoY 11
Next Q $0.13 $0.10 — $0.14 25% YoY 11
Current FY $0.41 $0.36 — $0.48 6% YoY 11
Next FY $0.53 $0.37 — $0.78 28% YoY 10

Top Institutional Holders

FundValueMove
BAILLIE GIFFORD & CO$85.3MADD
BlackRock, Inc.$80.3M
VANGUARD PORTFOLIO MANAGEMENT LLC$42.3M
VANGUARD CAPITAL MANAGEMENT LLC$36.9M
AMERIPRISE FINANCIAL INC$26.6MADD

Recent Insider Trades

DateInsiderTypeValue
Jun 11, 2026Maco MarylouA$0.00
Jun 11, 2026Ng AndrewA$0.00
Jun 11, 2026MITCHELL THEODOREA$0.00
Jun 11, 2026Paterson LydiaA$0.00
Jun 11, 2026McCarthy ChristopherA$0.00

Reddit Sentiment

75°
Bullish
Bearish Neutral Bullish
4 mentions 4 bullish 0 bearish
50 institutional holders with $470.2M total value (80,694,870 shares) as of 2026-Q1. Top holders: BAILLIE, BlackRock,, VANGUARD. Net buying activity: 18 institutions added/increased vs 16 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BAILLIE GIFFORD & CO14,651,016$85.3M18.1%ADD +97.0%
2BlackRock, Inc.13,804,748$80.3M17.1%
3VANGUARD PORTFOLIO MANAGEMENT LLC7,275,421$42.3M9.0%
4VANGUARD CAPITAL MANAGEMENT LLC6,346,742$36.9M7.9%
5AMERIPRISE FINANCIAL INC4,563,905$26.6M5.6%ADD +25.9%
6STATE STREET CORP3,137,179$18.3M3.9%
7DIMENSIONAL FUND ADVISORS LP2,730,508$15.9M3.4%
8GOLDMAN SACHS GROUP INC2,508,773$14.6M3.1%
9JUPITER ASSET MANAGEMENT LTD2,461,759$14.3M3.0%DOUBLED +7443.8%
10Connor, Clark & Lunn Investment Management Ltd.1,861,231$10.8M2.3%
11FEDERATED HERMES, INC.1,535,651$8.9M1.9%ADD +48.0%
12MORGAN STANLEY1,503,455$8.8M1.9%
13RENAISSANCE TECHNOLOGIES LLC1,385,193$8.1M1.7%TRIM -29.6%
14CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,373,641$8.0M1.7%
15DEUTSCHE BANK AG\1,179,433$6.9M1.5%
16Universal- Beteiligungs- und Servicegesellschaft mbH1,117,342$6.5M1.4%ADD +58.2%
17VANGUARD FIDUCIARY TRUST CO1,016,767$5.9M1.3%
18CITADEL ADVISORS LLC1,003,858$5.8M1.2%
19ARROWSTREET CAPITAL, LIMITED PARTNERSHIP886,601$5.2M1.1%TRIM -72.0%
20FMR LLC855,581$5.0M1.1%ADD +68.6%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
AMERIPRISE FINANCIAL INCADD3,623,7724,563,905+25.9%$26.6M2026-Q1
JUPITER ASSET MANAGEMENT LTDDOUBLED32,6332,461,759+7443.8%$14.3M2026-Q1
RENAISSANCE TECHNOLOGIES LLCTRIM1,968,0931,385,193-29.6%$8.1M2026-Q1
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPTRIM3,167,993886,601-72.0%$5.2M2026-Q1
Nuveen, LLCTRIM1,290,802493,857-61.7%$2.9M2026-Q1
FRANKLIN RESOURCES INCADD307,098482,165+57.0%$2.8M2026-Q1
GROUP ONE TRADING LLCDOUBLED3,792476,350+12462.0%$2.8M2026-Q1
Assenagon Asset Management S.A.TRIM390,294223,085-42.8%$1.3M2026-Q1
BANK OF AMERICA CORP /DE/TRIM416,613217,011-47.9%$1.3M2026-Q1
Mariner, LLCDOUBLED29,582190,352+543.5%$1.1M2026-Q1
Brevan Howard Capital Management LPDOUBLED37,399174,544+366.7%$1.0M2026-Q1
CWM, LLCDOUBLED64,334159,005+147.2%$925.4K2026-Q1
Cerity Partners LLCDOUBLED29,90671,289+138.4%$414.9K2026-Q1
WEALTH ENHANCEMENT ADVISORY SERVICES, LLCDOUBLED36,65977,011+110.1%$395.7K2026-Q1
CANADA PENSION PLAN INVESTMENT BOARDTRIM106,60059,300-44.4%$345.1K2026-Q1
Freestone Grove Partners LPADD25,59446,635+82.2%$271.4K2026-Q1
AmundiTRIM135,06844,416-67.1%$258.5K2026-Q1
Verition Fund Management LLCNEAR_EXIT233,34840,775-82.5%$237.3K2026-Q1
MANUFACTURERS LIFE INSURANCE COMPANY, THETRIM65,33638,509-41.1%$224.1K2026-Q1
Merit Financial Group, LLCDOUBLED12,73328,533+124.1%$166.1K2026-Q1
CAPTRUST FINANCIAL ADVISORSADD14,53528,386+95.3%$165.2K2026-Q1
Pictet Asset Management Holding SAADD15,25522,318+46.3%$129.9K2026-Q1
PRUDENTIAL FINANCIAL INCADD14,66522,035+50.3%$128.2K2026-Q1
SEI INVESTMENTS CONEAR_EXIT244,30417,417-92.9%$101.4K2026-Q1
M&T BANK CORPTRIM34,85016,435-52.8%$95.7K2026-Q1
13 unique insiders with 21 transactions. Net insider value: -$7.0M ($0.00 bought, $7.0M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 11, 2026Maco MarylouDirectorAWARD34,260
Jun 11, 2026Ng Andrew Y.DirectorAWARD34,260
Jun 11, 2026MITCHELL THEODOREDirectorAWARD34,260
Jun 11, 2026Paterson LydiaDirectorAWARD34,260
Jun 11, 2026McCarthy Christopher D.DirectorAWARD34,260
Jun 11, 2026ABBASI SOHAIBDirectorAWARD34,260
Jun 11, 2026Chang CarmenDirectorAWARD34,260
Jun 11, 2026SANDELL SCOTT DDirectorAWARD34,260
May 20, 2026Insight Holdings Group, LLC10%+ OwnerSELL935,596$5.24$4.9M
May 19, 2026Insight Holdings Group, LLC10%+ OwnerSELL290,305$5.41$1.6M
May 18, 2026Cardenas Alan BSVP, General CounselSELL9,139$5.52$50.4K
May 18, 2026Insight Holdings Group, LLC10%+ OwnerSELL78,628$5.69$447.3K
May 15, 2026Modica MarceloSVP, Chief People OfficerTAX W/H11,241$5.28$59.4K
May 15, 2026Cardenas Alan BSVP, General CounselTAX W/H9,201$5.28$48.6K
May 15, 2026Hart Gregory M.President & CEOTAX W/H46,069$5.28$243.2K
Mar 25, 2026Modica MarceloSVP, Chief People OfficerAWARD20,000
Mar 25, 2026Cardenas Alan BSVP, General CounselAWARD20,000
Mar 16, 2026Foley Michael D.SVP, Chief Financial OfficerAWARD350,000
Feb 23, 2026Cardenas Alan BSVP, General CounselAWARD41,498
Feb 23, 2026Modica MarceloSVP, Chief People OfficerAWARD41,498
Feb 3, 2026Hart Gregory M.President & CEOTAX W/H185,653$5.86$1.1M

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (67% buy). Based on 18 analysts: 3 strong buy, 9 buy, 5 hold, 1 sell, 0 strong sell.

Analyst Price Targets

$8.00 mean target +50.1% upside Strong Buy (2.25)
$5.50 Low $10.00 High
MetricValue
Current Price$5.33
Target Low$5.50
Target Mean$8.00
Target Median$7.75
Target High$10.00
# Analysts10
RecommendationStrong Buy (2.25)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.09 $0.07 $0.10 -28.9% +0.0% 0↑ 9↓ $0.2B 6.1% 11
Next Q
2026-09-30
$0.13 $0.10 $0.14 25.5% +0.0% 4↑ 5↓ $0.2B 6.5% 11
Current FY
2026-12-31
$0.41 $0.36 $0.48 5.8% +0.0% 1↑ 9↓ $0.8B 7.0% 11
Next FY
2027-12-31
$0.53 $0.37 $0.78 28.1% +0.0% 2↑ 4↓ $0.9B 6.2% 10

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.085
7d ago$0.085
30d ago$0.085
60d ago$0.105-0.019
90d ago$0.104-0.019
7 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Apr 27, 2026 BMO Capital MAINTAIN Outperform Outperform
Apr 24, 2026 JP Morgan MAINTAIN Overweight Overweight
Apr 24, 2026 Needham REITERATE Buy Buy
Feb 9, 2026 Goldman Sachs MAINTAIN Sell Sell
Feb 6, 2026 RBC Capital MAINTAIN Outperform Outperform
Feb 6, 2026 Keybanc MAINTAIN Overweight Overweight
Feb 6, 2026 Telsey Advisory Group MAINTAIN Outperform Outperform
Feb 6, 2026 Needham REITERATE Buy Buy
Jan 30, 2026 Telsey Advisory Group MAINTAIN Outperform Outperform
Jan 5, 2026 RBC Capital MAINTAIN Outperform Outperform

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263951067%
May 1, 20263951067%
Apr 1, 20263941071%
Mar 1, 202631051068%
Feb 1, 202631051068%
Jan 1, 202631051068%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

75°
Bullish
Bearish Neutral Bullish
4 mentions 4 bullish 0 bearish 4 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Jun 6, 2026160° Warm101
Jun 6, 2026160° Warm101
May 14, 2026160° Warm101
May 14, 2026160° Warm101

Recent Reddit Threads

r/wallstreetbets Neutral 11d 7h ago
Interesting read.
▲ 1 💬 0 ⚡ 0.5
Jun 16, 2026
short_volume
Short Volume: COUR — 63.6% short (1.8M / 2.8M)
Short: 1,778,983 | Exempt: 0 | TRF Vol: 2,796,777 | Short Ratio: 63.6% | Off-exchange volume (dark pool + OTC)
Jun 15, 2026
short_volume
Short Volume: COUR — 67.5% short (1.4M / 2.0M)
Short: 1,378,871 | Exempt: 3,218 | TRF Vol: 2,042,653 | Short Ratio: 67.5% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
short_volume
Short Volume: COUR — 61.9% short (1.7M / 2.8M)
Short: 1,721,788 | Exempt: 0 | TRF Vol: 2,781,948 | Short Ratio: 61.9% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: COUR — 68.9% short (1.1M / 1.6M)
Short: 1,127,232 | Exempt: 346 | TRF Vol: 1,636,034 | Short Ratio: 68.9% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: COUR — 61.6% short (1.4M / 2.3M)
Short: 1,393,015 | Exempt: 4 | TRF Vol: 2,261,078 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: COUR — 70.8% short (1.4M / 1.9M)
Short: 1,351,094 | Exempt: 115 | TRF Vol: 1,908,725 | Short Ratio: 70.8% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: COUR — 67.2% short (1.8M / 2.7M)
Short: 1,795,304 | Exempt: 0 | TRF Vol: 2,673,496 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: COUR — 55.9% short (1.6M / 2.9M)
Short: 1,604,849 | Exempt: 78 | TRF Vol: 2,870,492 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: COUR — 56.2% short (1.5M / 2.6M)
Short: 1,488,555 | Exempt: 992 | TRF Vol: 2,648,298 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: COUR — 58.2% short (1.5M / 2.6M)
Short: 1,519,418 | Exempt: 51 | TRF Vol: 2,608,490 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: COUR — 62.1% short (1.6M / 2.5M)
Short: 1,581,550 | Exempt: 0 | TRF Vol: 2,548,799 | Short Ratio: 62.1% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: COUR — 60.2% short (1.7M / 2.8M)
Short: 1,694,507 | Exempt: 0 | TRF Vol: 2,812,835 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: COUR — 56.4% short (1.7M / 3.0M)
Short: 1,695,756 | Exempt: 20,070 | TRF Vol: 3,008,813 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: COUR — 61.5% short (2.0M / 3.2M)
Short: 1,955,038 | Exempt: 1,050 | TRF Vol: 3,180,865 | Short Ratio: 61.5% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: COUR — 66.3% short (2.4M / 3.6M)
Short: 2,410,291 | Exempt: 0 | TRF Vol: 3,637,204 | Short Ratio: 66.3% | Off-exchange volume (dark pool + OTC)
Apr 1, 2026
Clinical Trial
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
Phase Phase 2 — COMPLETED